Chinese tariffs could raise price of prescriptions in US: 3 things to know

President Donald Trump's decision to increase tariffs for select Chinese imports by 25 percent may lead to higher prescription drug prices in the U.S., according to The Hill.

Here are three things to know.

1. President Trump's list of imports that may be hit with the increased tariffs include ingredients used to produce insulin, epinephrine and antidepressants.

2. According to the FDA, China is one of the largest suppliers of ingredients for domestic prescription drug manufacturers.

3. "We are concerned that the proposed tariffs may lead to increased costs of manufacturing for generics and biosimilars and thus higher prescription drug prices for patients in the U.S.," the Association for Accessible Medicines said in a statement.

More articles on business:

AI with an ROI — why natural language processing makes sense for healthcare
The future of the connected clinician
Amazon's ad business could hit $20B threshold in 2020

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers